BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 17311868)

  • 41. Assessment of CD105, α-SMA and VEGF expression in gastric carcinomas.
    Grigore D; Simionescu CE; Stepan A; Mărgăritescu C; Bălăşoiu M; Georgescu CC; Cernea D; Dumitrescu D
    Rom J Morphol Embryol; 2013; 54(3 Suppl):701-7. PubMed ID: 24322015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx.
    Chien CY; Su CY; Hwang CF; Chuang HC; Hsiao YC; Wu SL; Huang CC
    Head Neck; 2006 May; 28(5):441-6. PubMed ID: 16320363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
    Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
    Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
    Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
    Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
    Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma.
    Zvrko E; Mikic A; Vuckovic L
    Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
    El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
    Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
    Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
    Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
    Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
    Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
    Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
    World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance].
    Liu Y; Xue X; Wang F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):100-3. PubMed ID: 18476626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx].
    Gu X; Xu Y; Wu H; Xu X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(3):125-8. PubMed ID: 16646406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.
    Poon RT; Ng IO; Lau C; Yu WC; Yang ZF; Fan ST; Wong J
    J Clin Oncol; 2002 Apr; 20(7):1775-85. PubMed ID: 11919234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry.
    Bhatia JK; Chaudhary T; Boruah D; Bharadwaj R
    Med J Armed Forces India; 2022 Jul; 78(3):345-354. PubMed ID: 35855704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.
    Alexandrakis MG; Neonakis IK; Pappa CA; Konsolas I; Kokonozaki M; Vyzoukaki R; Soundoulounaki S; Xekalou A; Sfiridaki K; Tsirakis G
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1503-9. PubMed ID: 25773125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
    Behrem S; Zarkovic K; Eskinja N; Jonjic N
    Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
    Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
    Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
    Mineo TC; Ambrogi V; Baldi A; Rabitti C; Bollero P; Vincenzi B; Tonini G
    J Clin Pathol; 2004 Jun; 57(6):591-7. PubMed ID: 15166262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.